Pudafensine for vulvar pain study
Part of Women’s health & pregnancy clinical trials.
This trial tests a new medicine called pudafensine to see if it safely reduces pain in women with vulvodynia, a condition that causes pain when the vulvar area is touched.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with vulvodynia (pain in the vulvar area, especially when touched).
- Your vulvar pain is not caused by an infection like yeast or herpes.
- Your vulvar pain is not caused by a skin condition like lichen sclerosus.
- You do not have cancer or a history of cancer in the vulvar area.
- You do not have nerve damage or a nerve condition causing the pain.
- You do not have other pelvic pain conditions like endometriosis, interstitial cystitis, or pelvic floor problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a topical cream called ketotifen for treating a type of vulvar pain (secondary provoked vestibulodynia). The cream may help reduce pain at the vaginal opening, and you would apply it daily for several months.
This study tests a low dose of naltrexone (a pill that may help reduce pain) for vulvodynia, a condition causing long-lasting pain in the vulvar area. It aims to see if this treatment can ease the pain and improve quality of life.
This study compares two different surgery techniques for people with long-lasting, touch-triggered pain at the vaginal entrance (“vestibule”). You might be offered one of the surgical approaches and you’ll complete pain testing and follow-up measurements to see which technique works best.
This study tests whether biomodulation therapy combined with pelvic floor rehabilitation can help women with certain types of pelvic pain. It is for premenopausal women who were born female and are experiencing provoked vestibulodynia (pain at the vaginal opening) with or without vaginismus (tightness).
This trial tests whether a special light device (LED) applied to the vulvar area can reduce pain and discomfort from vulvodynia. If you have vulvodynia, this treatment might be a non-invasive way to help manage your symptoms.
This trial compares two hormone creams for women with vulvodynia (chronic pain at the opening of the vagina). One group will use a cream with both testosterone and estrogen, and the other group will use a cream with estrogen alone, to see which better reduces pain during sex or tampon use.
Hear when a new Vulvodynia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.